OptiChroniX develops digital therapeutics dedicated to improving brain health. It develops an application that tracks disease progression and treatment effectiveness through the use of biometrics and digital biomarkers, integrated with care records and various medical and lifestyle repositories. The company was founded in 2020 and is based in Bottmingen, Switzerland.

OptiChroniX develops digital therapeutics dedicated to improving brain health. It develops an application that tracks disease progression and treatment effectiveness through the use of biometrics and digital biomarkers, integrated with care records and various medical and lifestyle repositories. The company was founded in 2020 and is based in Bottmingen, Switzerland.

RelieVRx (formerly EaseVRx) is the first and only FDA-authorized at-home immersive virtual reality (VR) pain treatment indicated as adjunctive treatment for chronic lower back pain (CLBP).1,2

AppliedVR offers a virtual reality platform that provides patients with drug-free alternatives for managing pain and anxiety associated with medical procedures. It is designed to engage patients during all stages of procedures in hospitals and surgical centers. AppliedVR was founded in 2015 and is based in Los Angeles, California.

RelieVRx is a prescription-use immersive virtual reality system intended to provide adjunctive treatment based on cognitive behavioral therapy skills and other evidence-based behavioral methods for patients (age 18 and older) with a diagnosis of chronic lower back-pain (defined as moderate to severe pain lasting longer than three months). The device is intended for in-home use for the reduction of pain and pain interference associated with chronic lower back pain.